drugset / Trial / NCT04682184

A Study of Continuous Heart Rate Monitoring in Healthy Participants

NCT04682184

Completed 21 enrolled Eli Lilly and Company
RandomizedCrossoverOpen-labelBasic science

Summary

The main purpose of this study in healthy participants is to find out whether a heart rate monitor will accurately pick up changes in heart rate caused by 2 different medications (pseudoephedrine and metoprolol), on the background of daily activities. Participants will wear a patch heart rate and activity monitor on the chest for the entire study. The study will last about 36 days and may include up to seven visits to the study center.

Timeline

Start
2021-01-27
Primary completion
2021-03-25
Completion
2021-03-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule Oral
Subject Pseudoephedrine Small molecule Oral

Indications

No indication recorded.